JP2022510346A5 - - Google Patents
Info
- Publication number
- JP2022510346A5 JP2022510346A5 JP2021531369A JP2021531369A JP2022510346A5 JP 2022510346 A5 JP2022510346 A5 JP 2022510346A5 JP 2021531369 A JP2021531369 A JP 2021531369A JP 2021531369 A JP2021531369 A JP 2021531369A JP 2022510346 A5 JP2022510346 A5 JP 2022510346A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- alkyl
- group
- carbon atoms
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1819399.5A GB2579253A (en) | 2018-11-28 | 2018-11-28 | Antibacterial antisense agents |
| GB1819399.5 | 2018-11-28 | ||
| PCT/GB2019/053354 WO2020109792A1 (en) | 2018-11-28 | 2019-11-27 | Antibacterial antisense agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022510346A JP2022510346A (ja) | 2022-01-26 |
| JP2022510346A5 true JP2022510346A5 (cg-RX-API-DMAC7.html) | 2022-11-09 |
Family
ID=65024582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531369A Pending JP2022510346A (ja) | 2018-11-28 | 2019-11-27 | 抗菌アンチセンス剤 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220106595A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3887520A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022510346A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210098493A (cg-RX-API-DMAC7.html) |
| CN (1) | CN113366107A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019386368A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3121064A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB2579253A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020109792A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54130516A (en) * | 1978-03-31 | 1979-10-09 | Yuuichi Yamamura | Acyllnnacetylmuramylpeptide derivativeeantigen combination |
| US5185444A (en) | 1985-03-15 | 1993-02-09 | Anti-Gene Deveopment Group | Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
| US5217866A (en) | 1985-03-15 | 1993-06-08 | Anti-Gene Development Group | Polynucleotide assay reagent and method |
| EP0541486A1 (de) | 1991-11-07 | 1993-05-12 | Ciba-Geigy Ag | Polycyclische Konjugate |
| WO2006104530A1 (en) * | 2005-03-28 | 2006-10-05 | Cell Works Therapeutics, Inc. | Therapeutics targeted to renal cells |
| WO2014002039A1 (en) | 2012-06-27 | 2014-01-03 | Shire Ag | Amphetamine prodrugs |
| WO2014205451A2 (en) * | 2013-06-21 | 2014-12-24 | Isis Pharmaceuticals, Inc. | Compositions and methods for modulation of target nucleic acids |
| WO2015006740A2 (en) * | 2013-07-11 | 2015-01-15 | Alnylam Pharmaceuticals, Inc. | Oligonucleotide-ligand conjugates and process for their preparation |
| EP2845607A1 (en) | 2013-09-09 | 2015-03-11 | University of Vienna | Antisense oligonucleotides with improved pharmacokinetic properties |
| US9790495B2 (en) | 2014-05-16 | 2017-10-17 | Oregon State University | Antisense antibacterial compounds and methods |
| CA2948568A1 (en) | 2014-05-19 | 2015-11-26 | David Greenberg | Antisense antibacterial compounds and methods |
| WO2016108930A2 (en) | 2014-12-31 | 2016-07-07 | Geller Bruce L | Antisense antibacterial compounds and methods |
| WO2016172615A1 (en) | 2015-04-24 | 2016-10-27 | University Of Delaware | Synthetic n-acetyl-muramic acid derivatives and uses thereof |
| JPWO2017010575A1 (ja) * | 2015-07-16 | 2018-04-26 | 協和発酵キリン株式会社 | β2GPI遺伝子発現抑制核酸複合体 |
| AU2016379399B2 (en) | 2015-12-23 | 2022-12-08 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| US11142764B2 (en) | 2015-12-23 | 2021-10-12 | Board Of Regents, The University Of Texas System | Antisense antibacterial compounds and methods |
| US11180756B2 (en) * | 2017-03-09 | 2021-11-23 | Ionis Pharmaceuticals | Morpholino modified oligomeric compounds |
-
2018
- 2018-11-28 GB GB1819399.5A patent/GB2579253A/en not_active Withdrawn
-
2019
- 2019-11-27 CN CN201980090482.5A patent/CN113366107A/zh active Pending
- 2019-11-27 CA CA3121064A patent/CA3121064A1/en active Pending
- 2019-11-27 EP EP19816851.0A patent/EP3887520A1/en not_active Withdrawn
- 2019-11-27 JP JP2021531369A patent/JP2022510346A/ja active Pending
- 2019-11-27 WO PCT/GB2019/053354 patent/WO2020109792A1/en not_active Ceased
- 2019-11-27 KR KR1020217019995A patent/KR20210098493A/ko not_active Ceased
- 2019-11-27 AU AU2019386368A patent/AU2019386368A1/en not_active Abandoned
- 2019-11-27 US US17/296,748 patent/US20220106595A1/en not_active Abandoned